These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7398982)

  • 41. [Levamisole as an immunostimulating factor].
    Smogorzewska E
    Probl Med Wieku Rozwoj; 1979; 8():56-62. PubMed ID: 318115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunotherapy in infectious disease, autoimmunity and cancer.
    Spitler LE; Dau PC
    Acta Neurol Scand Suppl; 1977; 63():227-37. PubMed ID: 265668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Levamisole and its use in dermatologic therapy].
    Marcyniak-Górska M
    Przegl Dermatol; 1983; 70(5-6):563-8. PubMed ID: 6366926
    [No Abstract]   [Full Text] [Related]  

  • 44. Deficiency of nonspecific defence mechanism in a patient with chronic pyoderma.
    Kikindjanin V; Milakov J; Jovanović M; Poljacki M
    Dermatol Monatsschr; 1982 Jul; 168(7):472-6. PubMed ID: 7128881
    [No Abstract]   [Full Text] [Related]  

  • 45. [Levamisole-induced changes of cellular immunity in patients with staphyloderma and indications for levamisole administration].
    Lesnitskiĭ AI
    Vestn Dermatol Venerol; 1982; (1):14-9. PubMed ID: 6978577
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract]   [Full Text] [Related]  

  • 47. [Cancer today. Invitation to reflection].
    Lupo M; Pezza F
    Minerva Med; 1978 Jul; 69(34):2325-30. PubMed ID: 355936
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis.
    Bentley-Phillips CB; Cooper RC; Hallett AF
    Br J Dermatol; 1982 Jun; 106(6):687-95. PubMed ID: 7082573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levamisole: lack of immunopotentiation in a controlled trial.
    Whittingham S; Sharma DL
    Med J Aust; 1978 May; 1(10):569-70. PubMed ID: 150487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunologic state and effect of long-term levamisole therapy on selected immunologic parameters in children with steroid sensitive nephrotic syndrome during remission].
    Prandota J; Jankowski A; Szozda A
    Pol Tyg Lek; 1993 May 17-31; 48(20-22):455-9. PubMed ID: 8170809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levamisole in chronic inflammatory diseases.
    Wilton JM
    J Rheumatol Suppl; 1978; 4():101-13. PubMed ID: 366135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Significance of cellular immunity in children with chronic respiratory diseases].
    Endre L; Osváth P; Gergely A; Kelenhegyi K
    Orv Hetil; 1986 Oct; 127(43):2629-32. PubMed ID: 3785944
    [No Abstract]   [Full Text] [Related]  

  • 53. Pyoderma gangrenosum and myeloproliferative disorders. Report of a case and review of the literature.
    Romano J; Safai B
    Arch Intern Med; 1979 Aug; 139(8):932-4. PubMed ID: 288320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [State of cellular and humoral immunity in recurrent and chronic bronchopulmonary diseases in children before and after immunostimulation with levamisole].
    Błaszczyk E; Kulczyk BA
    Wiad Lek; 1985 Apr; 38(7):495-9. PubMed ID: 3874484
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of levamisole on the immunological reactivity of patients with chronic postoperative osteomyelitis].
    Linnik SA; Dzhaginian AI; Andreeva LN; Koz'mina-Sokolova IB
    Vestn Khir Im I I Grek; 1985 Sep; 135(9):51-4. PubMed ID: 4071910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pyoderma eczema and folliculitis with defective leucocyte and lymphocyte function: a new familial immunodeficiency disease responsive to a histamine-1 antagonist.
    Jung LK; Engelhard D; Kapoor N; Pih K; Good RA
    Lancet; 1983 Jul; 2(8343):185-7. PubMed ID: 6135027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinico-immunologic evaluation of the effect of decaris (levamisole) in chronic lymphoid leukemia].
    Streneva TN; Shalaev VA; Krylova IV
    Probl Gematol Pereliv Krovi; 1982 Sep; 27(9):20-3. PubMed ID: 6983689
    [No Abstract]   [Full Text] [Related]  

  • 58. [Nature of the disturbance of immune protection in diabetes mellitus and its correction with levamisole].
    Potemkin VV; Apanas'eva SN
    Probl Endokrinol (Mosk); 1982; 28(1):17-21. PubMed ID: 6977769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Double-blind cross-over study of levamisole as immunoprophylaxis for recurrent herpes progenitalis.
    Bierman SM
    Cutis; 1978 Mar; 21(3):352-4. PubMed ID: 343999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of pefloxacin in the treatment of complicated relapsing erysipelas].
    Kurmanova KB; Sulełmenova ZI; Sensatkhit K; Uteulin MN
    Antibiot Khimioter; 1997; 42(12):25-8. PubMed ID: 9480650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.